| pubmed-article:17021855 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17021855 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17021855 | lifeskim:mentions | umls-concept:C0000545 | lld:lifeskim |
| pubmed-article:17021855 | lifeskim:mentions | umls-concept:C0086153 | lld:lifeskim |
| pubmed-article:17021855 | lifeskim:mentions | umls-concept:C0449438 | lld:lifeskim |
| pubmed-article:17021855 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:17021855 | lifeskim:mentions | umls-concept:C1527249 | lld:lifeskim |
| pubmed-article:17021855 | lifeskim:mentions | umls-concept:C0333348 | lld:lifeskim |
| pubmed-article:17021855 | lifeskim:mentions | umls-concept:C1521739 | lld:lifeskim |
| pubmed-article:17021855 | lifeskim:mentions | umls-concept:C0332256 | lld:lifeskim |
| pubmed-article:17021855 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:17021855 | lifeskim:mentions | umls-concept:C2348609 | lld:lifeskim |
| pubmed-article:17021855 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:17021855 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:17021855 | pubmed:dateCreated | 2007-2-13 | lld:pubmed |
| pubmed-article:17021855 | pubmed:abstractText | The aim of the study was to assess the impact of an eicosapentanoic acid-containing protein and energy dense oral nutritional supplement (EPA-ONS) on nutritional and inflammatory status, quality of life (QOL), plasma phospholipids (PPL) and cytokine profile, tolerance of irinotecan-containing chemotherapy and EPA-ONS in patients with advanced colorectal cancer (CRC) receiving chemotherapy. | lld:pubmed |
| pubmed-article:17021855 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17021855 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17021855 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17021855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17021855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17021855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17021855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17021855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17021855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17021855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17021855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17021855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17021855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17021855 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17021855 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:17021855 | pubmed:issn | 0941-4355 | lld:pubmed |
| pubmed-article:17021855 | pubmed:author | pubmed-author:BealePhilip... | lld:pubmed |
| pubmed-article:17021855 | pubmed:author | pubmed-author:ClarkeStephen... | lld:pubmed |
| pubmed-article:17021855 | pubmed:author | pubmed-author:ReadJane AJA | lld:pubmed |
| pubmed-article:17021855 | pubmed:author | pubmed-author:ChildsAnnabel... | lld:pubmed |
| pubmed-article:17021855 | pubmed:author | pubmed-author:VolkerDianne... | lld:pubmed |
| pubmed-article:17021855 | pubmed:author | pubmed-author:SmithNarelleN | lld:pubmed |
| pubmed-article:17021855 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17021855 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:17021855 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17021855 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17021855 | pubmed:pagination | 301-7 | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:meshHeading | pubmed-meshheading:17021855... | lld:pubmed |
| pubmed-article:17021855 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17021855 | pubmed:articleTitle | Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. | lld:pubmed |
| pubmed-article:17021855 | pubmed:affiliation | Sydney Cancer Centre, Royal Prince Alfred Hospital and Concord Hospital, Sydney, Australia. | lld:pubmed |
| pubmed-article:17021855 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17021855 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17021855 | lld:pubmed |
